193 related articles for article (PubMed ID: 15246611)
21. Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice.
Wei JC; Huang YZ; Zhong DK; Kang L; Ishag H; Mao X; Cao RB; Zhou B; Chen PY
Biochem Biophys Res Commun; 2010 Jun; 396(4):787-92. PubMed ID: 20457131
[TBL] [Abstract][Full Text] [Related]
22. Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice.
Bharati K; Appaiahgari MB; Vrati S
Microbiol Immunol; 2005; 49(4):349-53. PubMed ID: 15840960
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice.
Kulkarni R; Sapkal G; Gore M
Virus Res; 2012 Dec; 170(1-2):118-25. PubMed ID: 23007095
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.
Lin CW; Liu KT; Huang HD; Chen WJ
Biotechnol Lett; 2008 Feb; 30(2):205-14. PubMed ID: 17876533
[TBL] [Abstract][Full Text] [Related]
25. Baker's yeast expressing the Japanese encephalitis virus envelope protein on its cell surface: induction of an antigen-specific but non-neutralizing antibody response.
Upadhyaya B; Manjunath R
Yeast; 2009 Jul; 26(7):383-97. PubMed ID: 19504623
[TBL] [Abstract][Full Text] [Related]
26. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
27. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
[TBL] [Abstract][Full Text] [Related]
28. Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.
Pan CH; Chen HW; Huang HW; Tao MH
J Virol; 2001 Dec; 75(23):11457-63. PubMed ID: 11689627
[TBL] [Abstract][Full Text] [Related]
29. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
[TBL] [Abstract][Full Text] [Related]
30. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
Wang KY; Guo YJ; Zhang YL; Lv K; Sun SH
Vaccine; 2007 May; 25(22):4429-36. PubMed ID: 17420075
[TBL] [Abstract][Full Text] [Related]
31. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
NAM JH; BANG HS; CHO HW; CHUNG YH
Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
[TBL] [Abstract][Full Text] [Related]
32. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
[TBL] [Abstract][Full Text] [Related]
34. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
35. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
[TBL] [Abstract][Full Text] [Related]
36. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
[TBL] [Abstract][Full Text] [Related]
37. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols.
Chen CT; Yi YC; Chiang SC; Liu KC; Lin YL; Lee ST
Microb Pathog; 2005; 38(2-3):53-62. PubMed ID: 15748807
[TBL] [Abstract][Full Text] [Related]
38. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity.
Xu G; Xu X; Li Z; He Q; Wu B; Sun S; Chen H
Vaccine; 2004 May; 22(15-16):1846-53. PubMed ID: 15121294
[TBL] [Abstract][Full Text] [Related]
39. Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models.
Xu XG; Wang ZS; Zhang Q; Li ZC; Zhao HN; Li W; Tong DW; Liu HJ
Vaccine; 2011 Jan; 29(4):636-43. PubMed ID: 21115062
[TBL] [Abstract][Full Text] [Related]
40. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
Khanam S; Khanna N; Swaminathan S
Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
